IGFBP-4 Gene Overexpression in the Nitrofen-Induced Hypoplastic Lung

Abstract

Purpose: The precise mechanism of pulmonary hypoplasia (HP) associated with congenital diaphragmatic hernia (CDH) remains unclear. Insulin-like growth factors (IGFs) play an essential role in fetal lung development through IGF receptors (IGFRs) by regulating cellular proliferation, differentiation and survival. It has been reported that the expression of genes involved in IGF-IGFR signaling is altered in the nitrofen-induced hypoplastic lung during the later stages of lung development. IGF-binding proteins (IGFBPs) control bioavailability, activity and disruption of IGFs through the high affinity IGFBP/IGF complexes. IGFBP-4 is a key inhibitor of IGF-IGFR signaling-mediated cell proliferation. It has been revealed that cell proliferation in fetal lung fibroblasts is inhibited by increased IGFBP-4 production. We hypothesized that IGFBP-4 gene expression is increased during the later stages of lung development in the nitrofen-induced CDH lung.

Methods: Pregnant Sprague-Dawley rats were exposed to either olive oil or nitrofen on day 9 (D9) of gestation. Fetuses were harvested by cesarean section on D18 and D21. Fetal lungs were divided into 3 groups: control, nitrofen without CDH [CDH(−)] and nitrofen with CDH [CDH(+)] (n=24 at each time point). Relative mRNA levels of IGFBP-4 were determined using real-time RT-PCR. Immunohistochemistry was performed to evaluate the protein expression of IGFBP-4.

Results: The relative expression levels of IGFBP-4 mRNA were significantly increased in CDH(−) and CDH(+) groups on D18 and D21 compared to controls. Immunohistochemistry showed increased IGFBP-4 expression in mesenchymal compartments on D18 and D21 in hypoplastic lungs compared to controls.

Conclusion: Overexpression of pulmonary IGFBP-4 during the later stages of lung development may contribute to pulmonary hypoplasia in the nitrofen-induced CDH model by inhibiting IGF-mediated cell proliferation.

Key words

IGFBP-4 - nitrofen - hypoplastic lung - congenital diaphragmatic hernia

References

• 1 Thebaud B, Mercier JC, Dinh-Xuan AT. Congenital diaphragmatic hernia. A cause of persistent pulmonary hypertension of the newborn, which lacks an effective therapy.  Biol Neonate. 1998;  74 323-336
• 2 Dillon PW, Cilley RE, Mauger D. The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia.  J Pediatr Surg. 2004;  39 307-312
• 3 Skari H, Bjornland K, Haugen G. et al . Congenital diaphragmatic hernia: influence of associated malformations on survival.  Arch Dis Child. 2000;  69 68-70
• 4 Petrini J, Damus K, Johnson RBJ. An overview of infant mortality and birth defects in the United States.  Teratology. 1997;  56 8-9
• 5 Taira T, Yamataka T, Miyazaki E. Comparison of the pulmonary vasculature in newborns and stillborns with congenital diaphragmatic hernia.  Pediatr Surg Int. 1998;  14 30-35
• 6 Noble B, Babiuk R, Clugston R. Mechanisms of the congenital diaphragmatic hernia-inducing teratogen nitrofen.  Am J Physiol Lung Cell Mol Physiol. 2007;  293 1087-1097
• 7 Schuller A, van Neck J, Beukenholdt R. et al . IGF, type I IGF receptor and IGF-binding protein mRNA expression in the developing mouse lung.  J Mol Endocrinol. 1995;  14 349-355
• 8 Price WA, Stiles AD. The insulin-like growth factor system and lung. In: Mendelson CR (ed) Endocrinology of the Lung. Totowa, NJ: Humana Press Inc; 2000: 201-224
• 9 Retsch-Bogart GZ, Moats-Staats BM, Howard K. et al . Cellular localization of messenger RNAs for insulin-like growth factors (IGFs), their receptors and binding proteins during fetal rat lung development.  Am J Respir Cell Mol Biol. 1996;  14 61-69
• 10 Nagata K, Masumoto K, Uesugi T. et al . Effect of insulin-like-growth factor and its receptors regarding lung development in fetal mice.  Pediatr Surg Int. 2007;  23 953-959
• 11 Ruttenstock E, Doi T, Dingemann J. et al . Downregulation of insulin-like growth factor binding protein 3 and 5 in nitrofen-induced pulmonary hypoplasia.  Pediatr Surg Int. 2010;  26 59-63
• 12 Ruttenstock E, Doi T, Dingemann J. et al . Insulin-like growth factor receptor type 1 and type 2 are downregulated in the nitrofen-induced hypoplastic lung.  J Pediatr Surg. 2010;  J Pediatr Surg. 2010 Jun;  45 (6) 1349-1353
• 13 Zhou R, Diehl D, Hoeflich A. et al . IGF-binding protein-4: biochemical characteristics and functional consequences.  Journal of Endocrinology. 2003;  178 177-193
• 14 Moats-Staats BM, Price WA, Xu L. et al . Regulation of the insulin-like growth factor system during normal rat lung development.  Am J Respir Cell Mol Biol. 1995;  12 56-64
• 15 Zhou R, Flaswinkel H, Schneider MR. et al . Insulin-like growth factor-binding protein-4 inhibits growth of the thymus in transgenic mice.  Journal of Molecular Endocrinology. 2004;  32 349-364
• 16 Zhang M, Smith EP, Kuroda H. et al . Targeted expression of a protease-resistant IGFBP-4 mutant in smooth muscle of transgenic mice results in IGFBP-4 stabilization and smooth muscle hypertrophy.  The Journal of Biological Chemistry. 2002;  277 21285-21290
• 17 Price WA. Peptide growth factors regulate insulin-like growth factor binding protein production by fetal rat lung fibroblasts.  Am J Respir Cell Mol Biol. 1999;  20 332-341
• 18 Ruttenstock E, Doi T, Dingemann J. et al . Insulin receptor is downregulated in the nitrofen-induced hypoplastic lung.  J Pediatr Surg. 2010;  45 948-952
• 19 George DK, Cooney TP, Chiu BK. Hypoplasia and immaturity of the terminal lung unit (acinus).  Am Rev Respir Dis. 1984;  136 947-950
• 20 Suen HC, Bloch KD, Donahoe PK. Antenatal glucocorticoid corrects pulmonary immaturity in experimentally induced congenital diaphragmatic hernia in rats.  Pediatr Res. 1994;  35 523-529
• 21 Al-Jumaily W, Bruce MC. The postnatal age of rat lung fibroblasts influences G1/S phase transition in vitro.  In Vitro Cell Dev Biol Anim. 1999;  35 410-416
• 22 Stewart CEH, Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors.  Physiol Rev. 1996;  76 1005-1026
• 23 Mohseni-Zadeh S, Binoux M. Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: an alternative mechanism in the regulation of IGF action.  Endocrinology. 1997;  138 5645-5648
• 24 Leal SM, Liu QJ, Huang SS. et al . The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor.  J Biol Chem. 1997;  272 20572-20576
• 25 Park JHY, Corkins MR, Vanderhoof JA. et al . Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation.  J Cell Physiol. 1996;  166 396-406
• 26 Singh P, Dai B, Dhruva B. et al . Episomal expression of sense and antisense insulin-like growth factor (IGF)-binding protein-4 complementary DNA alters the mitogenic response of a human colon cancer cell line (HT-29) by mechanisms that are independent of and dependent upon IGF-I.  Cancer Re. 1994;  54 6563-6570

Correspondence